GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism

Table 8

Uni- and multivariate analyses of variables that significantly affected TAC C/D ratios 3, 6, and 12 months after LT.

Significant variables	Univariate analysis		Multivariate analysis
	value	value	value	value
ABO compability	4.168	0.018	4.159	0.018
Donor CYP3A5	40.665	<0.001	20.998	<0.001
Recipient CYP3A5	28.398	<0.001	5.363	0.022

Note: TAC: tacrolimus; C/D: concentration-dose; LT: liver transplantation.